16th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Ligand Predictions Analysis
Results Home Table Browser
Target: 
Text
Models / Ligands Ligand scores
    #     Model     Group
    Name
     Target Ligand     LDDT_pli     RMSD     LDDT_lp     BB_RMSD
1. L3161LG386_2 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.726 1.902 0.912 0.523
2. L3161LG298_2 ShanghaiTech-human ligand_L0R_B_1.mol 0.726 1.902 0.912 0.523
3. L3161LG386_5 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.704 2.002 0.912 0.523
4. L3161LG298_5 ShanghaiTech-human ligand_L0R_B_1.mol 0.704 2.002 0.912 0.523
5. L3161LG298_1 ShanghaiTech-human ligand_L0R_B_1.mol 0.698 2.011 0.891 0.568
6. L3161LG386_1 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.698 2.011 0.891 0.568
7. L3161LG432_2 DIMAIO ligand_L0R_B_1.mol 0.657 1.823 0.764 0.785
8. L3161LG386_3 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.657 2.362 0.912 0.523
9. L3161LG298_3 ShanghaiTech-human ligand_L0R_B_1.mol 0.657 2.362 0.912 0.523
10. L3161LG432_5 DIMAIO ligand_L0R_B_1.mol 0.588 2.437 0.862 0.646
11. L3161LG207_1 MULTICOM_ligand ligand_L0R_B_1.mol 0.587 2.993 0.898 0.516
12. L3161LG298_4 ShanghaiTech-human ligand_L0R_B_1.mol 0.577 3.035 0.912 0.523
13. L3161LG386_4 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.577 3.035 0.912 0.523
14. L3161LG207_2 MULTICOM_ligand ligand_L0R_B_1.mol 0.565 3.209 0.898 0.516
15. L3161LG091_4 Huang-HUST ligand_L0R_B_1.mol 0.555 2.714 0.728 0.883
16. L3161LG207_3 MULTICOM_ligand ligand_L0R_B_1.mol 0.548 3.296 0.898 0.516
17. L3161LG420_2 Zou_aff2 ligand_L0R_B_1.mol 0.533 3.388 0.883 0.341
18. L3161LG204_4 Zou ligand_L0R_B_1.mol 0.533 3.388 0.883 0.341
19. L3161LG408_3 SNU-CHEM-lig ligand_L0R_B_1.mol 0.532 3.585 0.782 0.605
20. L3161LG091_1 Huang-HUST ligand_L0R_B_1.mol 0.504 3.418 0.728 0.883
21. L3161LG091_3 Huang-HUST ligand_L0R_B_1.mol 0.482 3.923 0.743 1.259
22. L3161LG091_2 Huang-HUST ligand_L0R_B_1.mol 0.481 3.782 0.731 1.043
23. L3161LG262_1 CoDock ligand_L0R_B_1.mol 0.475 3.420 0.748 0.818
24. L3161LG262_3 CoDock ligand_L0R_B_1.mol 0.475 3.420 0.748 0.818
25. L3161LG262_4 CoDock ligand_L0R_B_1.mol 0.475 3.420 0.748 0.818
26. L3161LG262_5 CoDock ligand_L0R_B_1.mol 0.475 3.420 0.748 0.818
27. L3161LG167_5 OpenComplex ligand_L0R_B_1.mol 0.397 4.336 0.536 3.207
28. L3161LG167_2 OpenComplex ligand_L0R_B_1.mol 0.372 4.634 0.584 1.290
29. L3161LG309_4 Koes ligand_L0R_B_1.mol 0.368 4.660 0.607 1.679
30. L3161LG420_3 Zou_aff2 ligand_L0R_B_1.mol 0.367 4.735 0.819 0.826
31. L3161LG204_2 Zou ligand_L0R_B_1.mol 0.357 5.017 0.783 0.748
32. L3161LG420_1 Zou_aff2 ligand_L0R_B_1.mol 0.357 5.017 0.783 0.748
33. L3161LG420_5 Zou_aff2 ligand_L0R_B_1.mol 0.348 5.050 0.782 0.738
34. L3161LG055_4 LCDD-team ligand_L0R_B_1.mol 0.345 11.983 0.942 0.271
35. L3161LG450_5 OpenComplex_Server ligand_L0R_B_1.mol 0.336 7.278 0.848 0.607
36. L3161LG432_4 DIMAIO ligand_L0R_B_1.mol 0.289 5.531 0.680 0.764
37. L3161LG408_4 SNU-CHEM-lig ligand_L0R_B_1.mol 0.284 12.550 0.882 0.332
38. L3161LG408_1 SNU-CHEM-lig ligand_L0R_B_1.mol 0.281 13.197 0.903 0.542
39. L3161LG167_1 OpenComplex ligand_L0R_B_1.mol 0.272 5.400 0.544 1.836
40. L3161LG294_1 KiharaLab ligand_L0R_B_1.mol 0.271 13.033 0.917 0.428
41. L3161LG408_5 SNU-CHEM-lig ligand_L0R_B_1.mol 0.269 12.768 0.920 0.316
42. L3161LG262_2 CoDock ligand_L0R_B_1.mol 0.264 10.770 0.748 0.818
43. L3161LG016_3 haiping ligand_L0R_B_1.mol 0.262 13.219 0.916 0.439
44. L3161LG227_3 KUMC ligand_L0R_B_1.mol 0.247 8.116 0.886 0.385
45. L3161LG016_5 haiping ligand_L0R_B_1.mol 0.246 13.238 0.916 0.439
46. L3161LG274_5 kozakovvajda ligand_L0R_B_1.mol 0.246 12.442 0.842 0.456
47. L3161LG274_4 kozakovvajda ligand_L0R_B_1.mol 0.246 12.442 0.842 0.456
48. L3161LG494_4 ClusPro ligand_L0R_B_1.mol 0.246 12.442 0.842 0.456
49. L3161LG494_5 ClusPro ligand_L0R_B_1.mol 0.246 12.442 0.842 0.456
50. L3161LG408_2 SNU-CHEM-lig ligand_L0R_B_1.mol 0.242 9.164 0.694 1.426
51. L3161LG227_1 KUMC ligand_L0R_B_1.mol 0.235 8.197 0.886 0.385
52. L3161LG016_4 haiping ligand_L0R_B_1.mol 0.234 13.049 0.916 0.439
53. L3161LG494_3 ClusPro ligand_L0R_B_1.mol 0.233 12.624 0.844 0.457
54. L3161LG274_3 kozakovvajda ligand_L0R_B_1.mol 0.233 12.624 0.844 0.457
55. L3161LG091_5 Huang-HUST ligand_L0R_B_1.mol 0.228 11.046 0.590 2.136
56. L3161LG420_4 Zou_aff2 ligand_L0R_B_1.mol 0.225 9.932 0.753 0.816
57. L3161LG494_2 ClusPro ligand_L0R_B_1.mol 0.225 12.517 0.845 0.456
58. L3161LG274_2 kozakovvajda ligand_L0R_B_1.mol 0.225 12.517 0.845 0.456
59. L3161LG494_1 ClusPro ligand_L0R_B_1.mol 0.224 12.685 0.843 0.456
60. L3161LG274_1 kozakovvajda ligand_L0R_B_1.mol 0.224 12.685 0.843 0.456
61. L3161LG450_3 OpenComplex_Server ligand_L0R_B_1.mol 0.217 11.928 0.848 0.607
62. L3161LG309_3 Koes ligand_L0R_B_1.mol 0.214 6.861 0.643 1.645
63. L3161LG055_2 LCDD-team ligand_L0R_B_1.mol 0.212 11.513 0.942 0.271
64. L3161LG207_4 MULTICOM_ligand ligand_L0R_B_1.mol 0.212 11.253 0.806 0.928
65. L3161LG016_2 haiping ligand_L0R_B_1.mol 0.211 12.699 0.916 0.439
66. L3161LG227_4 KUMC ligand_L0R_B_1.mol 0.210 8.498 0.886 0.385
67. L3161LG227_2 KUMC ligand_L0R_B_1.mol 0.209 8.414 0.886 0.385
68. L3161LG204_1 Zou ligand_L0R_B_1.mol 0.208 8.662 0.905 0.473
69. L3161LG204_5 Zou ligand_L0R_B_1.mol 0.203 8.237 0.914 0.482
70. L3161LG055_5 LCDD-team ligand_L0R_B_1.mol 0.200 12.069 0.942 0.271
71. L3161LG432_1 DIMAIO ligand_L0R_B_1.mol 0.199 8.163 0.576 1.666
72. L3161LG204_3 Zou ligand_L0R_B_1.mol 0.197 8.645 0.908 0.481
73. L3161LG201_3 Drugit ligand_L0R_B_1.mol 0.193 10.071 0.849 0.558
74. L3161LG227_5 KUMC ligand_L0R_B_1.mol 0.188 8.482 0.886 0.385
75. L3161LG201_2 Drugit ligand_L0R_B_1.mol 0.187 7.693 0.845 0.469
76. L3161LG055_1 LCDD-team ligand_L0R_B_1.mol 0.186 10.344 0.942 0.271
77. L3161LG432_3 DIMAIO ligand_L0R_B_1.mol 0.180 8.561 0.834 0.468
78. L3161LG207_5 MULTICOM_ligand ligand_L0R_B_1.mol 0.176 11.095 0.781 0.982
79. L3161LG016_1 haiping ligand_L0R_B_1.mol 0.175 12.427 0.916 0.439
80. L3161LG008_5 HADDOCK ligand_L0R_B_1.mol 0.174 9.791 0.892 0.652
81. L3161LG008_4 HADDOCK ligand_L0R_B_1.mol 0.168 10.436 0.910 0.556
82. L3161LG008_3 HADDOCK ligand_L0R_B_1.mol 0.158 10.212 0.882 0.647
83. L3161LG309_1 Koes ligand_L0R_B_1.mol 0.156 8.596 0.647 1.650
84. L3161LG008_2 HADDOCK ligand_L0R_B_1.mol 0.151 10.335 0.869 0.615
85. L3161LG164_5 McGuffin ligand_L0R_B_1.mol 0.149 11.357 0.657 1.587
86. L3161LG082_1 VnsDock ligand_L0R_B_1.mol 0.149 12.284 0.891 0.533
87. L3161LG167_3 OpenComplex ligand_L0R_B_1.mol 0.148 13.143 0.537 1.966
88. L3161LG008_1 HADDOCK ligand_L0R_B_1.mol 0.148 10.318 0.871 0.723
89. L3161LG191_2 Schneidman ligand_L0R_B_1.mol 0.142 9.594 0.666 1.737
90. L3161LG191_3 Schneidman ligand_L0R_B_1.mol 0.135 10.396 0.663 1.768
91. L3161LG191_1 Schneidman ligand_L0R_B_1.mol 0.133 9.768 0.666 1.737
92. L3161LG164_4 McGuffin ligand_L0R_B_1.mol 0.116 10.876 0.657 1.587
93. L3161LG309_2 Koes ligand_L0R_B_1.mol 0.114 9.939 0.647 1.650
94. L3161LG164_3 McGuffin ligand_L0R_B_1.mol 0.097 11.044 0.657 1.587
95. L3161LG201_4 Drugit ligand_L0R_B_1.mol 0.095 11.361 0.816 0.442
96. L3161LG164_1 McGuffin ligand_L0R_B_1.mol 0.081 11.233 0.657 1.587
97. L3161LG450_2 OpenComplex_Server ligand_L0R_B_1.mol 0.078 11.687 0.848 0.607
98. L3161LG450_1 OpenComplex_Server ligand_L0R_B_1.mol 0.060 12.346 0.848 0.607
99. L3161LG464_5 PocketTracer ligand_L0R_B_1.mol 0.057 15.706 0.656 1.689
100. L3161LG464_3 PocketTracer ligand_L0R_B_1.mol 0.048 15.405 0.656 1.689
101. L3161LG464_1 PocketTracer ligand_L0R_B_1.mol 0.045 14.158 0.656 1.689
102. L3161LG201_5 Drugit ligand_L0R_B_1.mol 0.037 14.662 0.869 0.417
103. L3161LG464_2 PocketTracer ligand_L0R_B_1.mol 0.023 14.095 0.656 1.689
104. L3161LG201_1 Drugit ligand_L0R_B_1.mol 0.019 18.672 0.765 0.823
105. L3161LG450_4 OpenComplex_Server ligand_L0R_B_1.mol 0.012 16.212 0.848 0.607
106. L3161LG464_4 PocketTracer ligand_L0R_B_1.mol 0.007 16.421 0.656 1.689
107. L3161LG055_3 LCDD-team ligand_L0R_B_1.mol 0.004 17.736 0.942 0.271
108. L3161LG167_4 OpenComplex ligand_L0R_B_1.mol 0.000 17.593 0.508 1.618
109. L3161LG164_2 McGuffin ligand_L0R_B_1.mol 0.000 35.347 0.663 1.590
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2024, University of California, Davis
Terms of Use